FluMist approved for self-administration in the US - astrazeneca.com
WEB12 hours ago · FluMist has been approved in the US as the only self-administered influenza vaccine.FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1. The approval by the US Food and Drug Administration (FDA) was based on a comprehensive submission, which included results from a ...
FDA approves first flu vaccine that can be self-administered at …
WEB9 hours ago · Link Copied! The FDA approved FluMist as the first flu vaccine that can be self-administered at home. Sarah Silbiger/Getty Images. The US Food and Drug Administration on Friday approved the first ...
Nasal Flu Vaccine Is Approved for At-Home Use
WEB10 hours ago · Sept. 20, 2024, 2:46 p.m. ET. The Food and Drug Administration on Friday authorized at-home use of FluMist, opening the door for needle-shy people to have easy access to a nasal spray vaccine that ...
FLUMIST approved for self-administration in the US
WEB9 hours ago · Iskra Reic, Executive Vice President, Vaccines and Immune Therapies, AstraZeneca, said: “The approval of FLUMIST for self-administration is an important step forward in making vaccines more ...
FDA approves first self-administered flu vaccine spray - CBS News
WEB9 hours ago · The FDA approved AstraZeneca's FluMist flu vaccine spray for self-administered use at home. ... Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the ...
US Food and Drug Administration accepts for review AstraZeneca…
WEBOct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA). If approved, FluMist will be the first flu vaccine available to be self-administered by eligible patients or administered by caregivers ...
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
WEB13 hours ago · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used ...
FDA approves first at-home flu vaccine in U.S., a nasal spray
WEB11 hours ago · Sept. 20, 2024. Senior Writer, Infectious Diseases. The Food and Drug Administration on Friday approved AstraZeneca’s bid to allow its nasal spray influenza vaccine, FluMist, to be sold for home ...
No needles required: The FDA approves an at-home flu vaccine
WEB10 hours ago · FluMist itself is not new — the live attenuated influenza vaccine has had FDA approval for more than two decades. But the ability for adults to order the vaccine at home to administer to people ...
FDA approves first nasal spray flu vaccine for use at home
WEB5 hours ago · By Sabrina Malhi. September 20, 2024 at 7:45 p.m. EDT. The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be ...
Skip to content